Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 15.35
+0.10 (0.66%)
Dec 31, 2025, 2:34 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 8.94 billion as of December 31, 2025. Its market cap has decreased by -15.97% in one year.
Market Cap
8.94B
Enterprise Value
4.10B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
15.35
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 8.94B, a decrease of -61.02%. That is a compound annual growth rate of -32.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 174.75B |
| Lotus Pharmaceutical | 73.63B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 30.94B |